Jiang, Haiyan,Diao, Lei,Li, Shuanglian,Cobb, Paula
申请号：
AU2018206758
公开号：
AU2018206758A1
申请日:
2018.07.18
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018206758A120180809.pdf#####ABSTRACT The present invention provides methods of administering a clotting factor by a fixed dosing regimen； methods of reducing, ameliorating, or preventing one or more symptoms of a bleeding disease or disorder； and a kit comprising a dotting factor useful for a fixed dosing regimen. While plasma-derived and recombinant clotting factor products allow hemophilia patients to live longer and healthier, hemophilia still remains one of the most costly and complex conditions to manage.
